Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis

Background and Objectives: Local and distant relapse (LR, DR) in breast cancer vary according to its molecular subtypes, with triple-negative breast cancer (TNBC) being the most aggressive. The surgical resection margin width (SRMW) for breast-conserving surgery (BCS) has been intensely debated, especially for the aforementioned subtype. The aim of this study was to examine the impact of SRMW on LR following BCS in TNBC patients. Materials and Methods: We conducted a retrospective study including all patients with TNBC for whom BCS was performed between 2005 and 2014. Results: Final analysis included a total of 92 patients, with a median tumor size of 2.5 cm (range 0–5 cm) and no distant metastasis at the time of diagnosis. A total of 87 patients had received neoadjuvant and/or adjuvant chemotherapy, and all patients had received adjuvant whole-breast radiotherapy. After a median follow-up of 110.7 months (95% CI, 95.23–126.166), there were 5 local recurrences and 8 regional/distant recurrences with an overall LR rate of 5.4%. The risk of LR and DR was similar between groups of patients with several SRMW cut-off values. Conclusions: Our study supports a safe “no ink on tumor” approach for TNBC patients treated with BCS.

• Publication year

  2021

• Venue

  Medicina

• Publication date

  2021-02-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.3390/medicina57030203PMID 33652670PMCID 7996718
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of 2014 margin guidelines on re-excision and recurrence rates after breast conserving surgery: A multi-institution retrospective study

  2020cited by this paper
• Impact of the SSO-ASTRO Margin Guideline on Rates of Re-excision After Lumpectomy for Breast Cancer: A Meta-analysis

  2019cited by this paper
• Margins in Breast-Conserving Surgery After Neoadjuvant Therapy

  2018cited by this paper
• Evaluating the Effect of Margin Consensus Guideline Publication on Operative Patterns and Financial Impact of Breast Cancer Operation.

  2018cited by this paper
• Practical consensus recommendations for tumor margins and breast conservative surgery

  2018cited by this paper
• Quality of life of breast cancer survivors following breast-conserving therapy versus mastectomy: a multicenter study in Taiwan

  2017cited by this paper
• Less is more. Breast conservation might be even better than mastectomy in early breast cancer patients.

  2017cited by this paper
• Changes in margin re‐excision rates: Experience incorporating the “no ink on tumor” guideline into practice

  2017cited by this paper
• Reexcision Surgery for Breast Cancer: An Analysis of the American Society of Breast Surgeons (ASBrS) MasterySM Database Following the SSO-ASTRO “No Ink on Tumor” Guidelines

  2016cited by this paper
• Locoregional Recurrence by Tumor Biology in Breast Cancer Patients after Preoperative Chemotherapy and Breast Conservation Treatment

  2016cited by this paper
• Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.

  2015cited by this paper
• Evidence-based Rating: B Personal Rating: 3 Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL

  2015cited by this paper
• Assessment of Practice Patterns Following Publication of the SSO–ASTRO Consensus Guideline on Margins for Breast-Conserving Therapy in Stage I and II Invasive Breast Cancer

  2015cited by this paper
• Basal Subtype, as Approximated by Triple-Negative Phenotype, is Associated with Locoregional Recurrence in a Case–Control Study of Women with 0–3 Positive Lymph Nodes After Mastectomy

  2014cited by this paper
• Effect of Margin Width on Local Recurrence in Triple-Negative Breast Cancer Patients Treated with Breast-Conserving Therapy

  2014influential reference
• Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer.

  2014influential reference
• Clinically Meaningful Tumor Reduction Rates Vary by Prechemotherapy MRI Phenotype and Tumor Subtype in the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

  2013cited by this paper
• Margin status and the risk of local recurrence in patients with early-stage breast cancer treated with breast-conserving therapy

  2013cited by this paper
• ["Less is more"].

  2013cited by this paper
• Favorable prognosis in patients with T1a/T1bN0 triple‐negative breast cancers treated with multimodality therapy

  2012cited by this paper
• Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype

  2012cited by this paper
• Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation

  2011cited by this paper
• Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy.

  2011cited by this paper
• Meta-analysis of the impact of surgical margins on local recurrence in women with early-stage invasive breast cancer treated with breast-conserving therapy.

  2010cited by this paper
• Comparison of margin assessment by radial and shave sections in wide local excision specimens for invasive carcinoma of the breast

  2010cited by this paper
• Breast cancer subtypes and the risk of local and regional relapse.

  2010cited by this paper
• Comparison of quality of life, satisfaction with surgery and shoulder-arm morbidity in breast cancer survivors submitted to breast-conserving therapy or mastectomy followed by immediate breast reconstruction

  2010cited by this paper
• Initial margin status for invasive ductal carcinoma of the breast and subsequent identification of carcinoma in reexcision specimens.

  2010cited by this paper
• Gene-expression signatures in breast cancer.

  2009cited by this paper
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• Triple-Negative Breast Cancer and Obesity in a Rural Appalachian Population

  2008cited by this paper
• Triple-negative breast cancer: therapeutic options.

  2007cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials

  2007cited by this paper
• Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.

  2006cited by this paper
• Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials.

  2005cited by this paper
• Quality of Life Following Breast‐Conserving Therapy or Mastectomy: Results of a 5‐Year Prospective Study

  2004cited by this paper
• Seroma formation after surgery for breast cancer

  2004cited by this paper
• Vascular endothelial growth factor is associated with the efficacy of endocrine therapy in patients with advanced breast carcinoma

  2004cited by this paper
• Breast conservation after neoadjuvant chemotherapy: the MD Anderson cancer center experience.

  2004cited by this paper
• Gene-expression signatures in breast cancer.

  2003cited by this paper
• Eighteen‐year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy

  2003cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast

  2002cited by this paper
• Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer.

  2002cited by this paper
• Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

  2002cited by this paper
• [Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial].

  2001cited by this paper
• Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial.

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction.

  2000cited by this paper
• The value of breast lumpectomy margin assessment as a predictor of residual tumor burden.

  1997cited by this paper
• Determinants of positive histologic margins and residual tumor after lumpectomy for early breast cancer: A prospective study with special reference to touch preparation cytology

  1997cited by this paper

• No citing papers are available for this paper.